India, Aug. 27 -- Fangzhou Inc. (6086.HK), an AI-driven Internet healthcare company, reported its interim results for the six months ended June 30, 2026, highlighting continued revenue and profit growth alongside expansion of its user, physician and pharmaceutical networks.
The company continued to advance its "AI + chronic care" strategy, integrating artificial intelligence across patient services, physician support, supply-chain management and internal operations.
H1 2026 Financial Highlights
Fangzhou reported revenue of RMB1.82 billion, up 22.2% year-over-year from RMB1.49 billion in the first half of 2025.
Adjusted net profit increased 6.4% to RMB18.7 million from RMB17.58 million in the prior-year period.
The company expanded its ...